USPTO 2015–2025 USPTO PatentsView US Corporation

Verily Life Sciences Llc

USPTO PatentsView assignee record - 926 granted patents across 141 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

926

Total patents granted

141

CPC technology areas

18.8

Avg claims per patent

+59%

5-year filing velocity

The verdict

Verily holds 926 US patents across 141 technology areas, rank #478 of 50,000 tracked assignees.

#478
of 50,000 US assignees by volume: Top 2%
by Innovation Score (64.6/100): 18.8
avg claims per patent: +59%
filing velocity, last 5 yrs

Portfolio overview

Verily Life Sciences Llc has been granted 926 US utility patents between 2016 and 2025, placing Verily Life Sciences Llc at rank #478 across all assignees tracked by PlainPatent. This portfolio spans 141 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Verily Life Sciences Llc is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Verily sits between Wacom Co., Ltd. (933 patents, rank #474) and THE University OF Tokyo (920 patents, rank #482) - the closest US assignees by grant volume. The composite Innovation Score of 64.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 568 grants, compared with 358 in the 2015–2019 window, a +59% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Verily Life Sciences Llc's 18.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Verily Life Sciences Llc against peers pursuing similar technology classes.

Wacom

933
Lumileds

930
IHI

928
Level 3 Communica…

928
ZEON

926
Verily Life Scien… ◀

926
Eaton

924
Baidu USA

922
THE University OF…

920

What this shows Verily holds 926 patents at rank #478, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Verily

By rank, the assignees closest to #478 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Verily's primary technology class.

Verily's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

65 Top 2% higher than 98% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Verily Life Sciences Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	36	3.9%
2017	85	9.2%
2018	110	11.9%
2019	127	13.7%
2020	131	14.1%
2021	109	11.8%
2022	89	9.6%
2023	87	9.4%
2024	82	8.9%
2025	70	7.6%

Which technologies does Verily Life Sciences Llc patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 474

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 152

G02C - SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES 147

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 95

G06F - ELECTRIC DIGITAL DATA PROCESSING 93

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 85

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 82

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 69

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 63

G06N - COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS 54

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 51

H04N - PICTORIAL COMMUNICATION, e.g. TELEVISION 48

A01K - ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS 43

H04B - TRANSMISSION 40

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 38

Top 15 of 141 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Diversified

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#478

Across all tracked assignees

Innovation Score

64.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Verily Life Sciences Llc hold?

Verily Life Sciences Llc holds 926 US granted patents filed between 2016 and 2025, spanning 141 technology areas.

What is Verily Life Sciences Llc's Innovation Score?

Verily Life Sciences Llc has an Innovation Score of 64.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Verily Life Sciences Llc focus on?

Verily Life Sciences Llc's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 474 patents. The company has filed patents in 141 CPC subclasses total.

Is Verily Life Sciences Llc's patent filing rate increasing or decreasing?

Verily Life Sciences Llc's recent filing velocity is +59% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Verily Life Sciences Llc's patents?

Verily Life Sciences Llc's patents average 18.8 claims each. This falls within the standard range, providing solid legal coverage.

How is the Verily Life Sciences Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Verily's 926 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Verily ranks #478 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.